Paul Cordero1, Jiawei Li, Jude A Oben. 1. aInstitute for Liver and Digestive Health, University College London bDepartment of Gastroenterology and Hepatology, Guy's and St Thomas' Hospital, NHS Foundation Trust, London, UK.
Abstract
PURPOSE OF REVIEW: After the study of the gene code as a trigger for obesity, epigenetic code has appeared as a novel tool in the diagnosis, prognosis and treatment of obesity, and its related comorbidities. This review summarizes the status of the epigenetic field associated with obesity, and the current epigenetic-based approaches for obesity treatment. RECENT FINDINGS: Thanks to technical advances, novel and key obesity-associated polymorphisms have been described by genome-wide association studies, but there are limitations with their predictive power. Epigenetics is also studied for disease association, which involves decoding of the genome information, transcriptional status and later phenotypes. Obesity could be induced during adult life by feeding and other environmental factors, and there is a strong association between obesity features and specific epigenetic patterns. These patterns could be established during early life stages, and programme the risk of obesity and its comorbidities during adult life. Furthermore, recent studies have shown that DNA methylation profile could be applied as biomarkers of diet-induced weight loss treatment. SUMMARY: High-throughput technologies, recently implemented for commercial genetic test panels, could soon lead to the creation of epigenetic test panels for obesity. Nonetheless, epigenetics is a modifiable risk factor, and different dietary patterns or environmental insights during distinct stages of life could lead to rewriting of the epigenetic profile.
PURPOSE OF REVIEW: After the study of the gene code as a trigger for obesity, epigenetic code has appeared as a novel tool in the diagnosis, prognosis and treatment of obesity, and its related comorbidities. This review summarizes the status of the epigenetic field associated with obesity, and the current epigenetic-based approaches for obesity treatment. RECENT FINDINGS: Thanks to technical advances, novel and key obesity-associated polymorphisms have been described by genome-wide association studies, but there are limitations with their predictive power. Epigenetics is also studied for disease association, which involves decoding of the genome information, transcriptional status and later phenotypes. Obesity could be induced during adult life by feeding and other environmental factors, and there is a strong association between obesity features and specific epigenetic patterns. These patterns could be established during early life stages, and programme the risk of obesity and its comorbidities during adult life. Furthermore, recent studies have shown that DNA methylation profile could be applied as biomarkers of diet-induced weight loss treatment. SUMMARY: High-throughput technologies, recently implemented for commercial genetic test panels, could soon lead to the creation of epigenetic test panels for obesity. Nonetheless, epigenetics is a modifiable risk factor, and different dietary patterns or environmental insights during distinct stages of life could lead to rewriting of the epigenetic profile.
Authors: Elizabeth T Jensen; Jelske W van der Burg; Thomas M O'Shea; Robert M Joseph; Elizabeth N Allred; Tim Heeren; Alan Leviton; Karl C K Kuban Journal: J Pediatr Date: 2017-03-21 Impact factor: 4.406
Authors: Alan Leviton; Stephen R Hooper; Scott J Hunter; Megan N Scott; Elizabeth N Allred; Robert M Joseph; T Michael O'Shea; Karl Kuban Journal: Pediatr Neurol Date: 2017-12-21 Impact factor: 3.372
Authors: Vi Nguyen; Jiawei Li; Jaslyn Gan; Paul Cordero; Shuvra Ray; Alessandro Solis-Cuevas; Mai Khatib; Jude A Oben Journal: Can J Gastroenterol Hepatol Date: 2017-12-26
Authors: Suresh Ambati; Ping Yu; Elizabeth C McKinney; Muthugapatti K Kandasamy; Diane Hartzell; Clifton A Baile; Richard B Meagher Journal: BMC Obes Date: 2016-07-19